50 unchanged sentences
001-40551), filed with the Securities and Exchange Commission on March 15, 2023).
−Removed: 4.1 Amended and Restated Investors’ Rights Agreement, by and among the Registrant and certain of its stockholders, dated November 20, 2020 (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement on Form S-1 (File No.
−Removed: 333-256945), filed with the Securities and Exchange Commission on June 9, 2021).
4.1 Description of the Company’s Common Stock (incorporated by reference to Exhibit 4.2 to the Company’s Annual Report on Form 10-K (File No.
11 unchanged sentences
333-256945), filed with the Securities and Exchange Commission on June 9, 2021).
−Removed: Number Description of Exhibit
10.7+ Form of Indemnification Agreement with Executive Officers and Directors (incorporated by reference to Exhibit 10.6 to the Company’s Registration Statement on Form S-1/A (File No.
333-256945), filed with the Securities and Exchange Commission on June 24, 2021) .
+Added: Number Description of Exhibit
10.8+ Amended and Restated Executive Employment Agreement, by and between the Registrant and Daniel O’Connell (incorporated by reference to Exhibit 10.7 to the Company’s Annual Report on Form 10-K (File No.
2 unchanged sentences
001-40551), filed with the Securities and Exchange Commission on March 28, 2022).
−Removed: 10.10+ Amended and Restated Employment Agreement, by and between the Registrant and Derek Meisner (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q (File No.
+Added: 10.10+ Executive Employment Agreement, by and between the Registrant and James Doherty (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q (File No.
001-40551), filed with the Securities and Exchange Commission on May 13, 2025).
−Removed: Lease Agreement, by and between the Registrant and Price-Poore House, LLC, dated August 1, 2024.
10.11 Lease, by and between Registrant and DIV Washington, LLC, dated September 11, 2023 (incorporated by reference to Exhibit 10.13 to the Company’s Annual Report on Form 10-K (File No.
4 unchanged sentences
001-40551), filed with the Securities and Exchange Commission on March 26, 2024).
−Removed: Amended and Restated Insider Trading Policy.
+Added: 10.14 Collaboration, Option, and License Agreement by and between the Company and JCR Pharmaceuticals Co., Ltd., dated July 15, 2025 (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q (File No.
+Added: 001-40551), filed with the Securities and Exchange Commission on August 1 2 , 2025) .
+Added: 19.1 Amended and Restated Insider Trading Policy (incorporated by reference to Exhibit 19.1 to the Company ' s Annual Report on Form 10-K (File No.
+Added: 001-40551), filed with the Securities and Exchange Commission on March 27, 2025).
23.1* Consent of Ernst & Young LLP, independent registered accounting firm.
35 unchanged sentences
/s/ William Matthew Zuga Chief Financial Officer and Chief Business Officer March 26, 2026
−Removed: William Matthew Zuga (Principal Financial Officer and Principal Accounting
+Added: William Matthew Zuga (Principal Financial Officer and Principal Accounting Officer)
/s/ Kimberlee C.
3 unchanged sentences
Fountain, M.D.
+Added: /s/ George Golumbeski
+Added: March 26, 2026
+Added: George Golumbeski, Ph.D.
/s/ Jeffrey L.
5 unchanged sentences
/s/ Laura Stoppel Director March 26, 2026
−Removed: Laura Stoppel, PhD
+Added: Laura Stoppel, Ph.D.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.